Back to series
#ESC2021: EMPEROR-Preserved Trial: Empagliflozin Outcome Trial in Patients with Chronic Heart Failure with Preserved Ejection Fraction
Medshr Editor

#ESC2021: EMPEROR-Preserved Trial: Empagliflozin Outcome Trial in Patients with Chronic Heart Failure with Preserved Ejection Fraction

Medshr Editor
Expected completion time: 15 mins
0.25 CPD Credit

Highlights from #ESC2021

Sign up to start learning
,